Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma
- 1 September 2000
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 63 (2), 163-169
- https://doi.org/10.1023/a:1006420615690
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The type I growth factor receptors in human breast cancerBreast Cancer Research and Treatment, 1994
- Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.Proceedings of the National Academy of Sciences, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.Proceedings of the National Academy of Sciences, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomasCell, 1982
- Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblastsNature, 1981